Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 52, 2022 - Issue 1
Submit an article Journal homepage
97
Views
4
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

The metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C] cetagliptin in healthy volunteers

Jinmiao Lua Xiangya School of Pharmaceutical Sciences, Central South University, Hunan, China;b CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaORCID Iconhttps://orcid.org/0000-0002-3782-6645View further author information
ORCID Icon,
Yicong Bianc Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
,
Hua Zhangc Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
,
Dong Tangb CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Xusheng Tianb CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Xinyi Zhoub CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Zengyan Xub CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Yating Xiongd Value Pharmaceutical Services Co., Ltd, Jiangsu, ChinaView further author information
,
Zheming Gud Value Pharmaceutical Services Co., Ltd, Jiangsu, ChinaView further author information
,
Zhenwen Yud Value Pharmaceutical Services Co., Ltd, Jiangsu, ChinaView further author information
,
Tong Wangb CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Juping Dingb CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaView further author information
,
Qiang Yub CGeneTech (Suzhou, China) Co., Ltd, Jiangsu, ChinaCorrespondence[email protected]
View further author information
&
Jinsong Dinga Xiangya School of Pharmaceutical Sciences, Central South University, Hunan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 38-45 | Received 17 Sep 2021, Accepted 02 Nov 2021, Published online: 21 Feb 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jinmiao Lu, Yan Hao, Fuzhi Zhang, Huiping Pan, Juping Ding, Qiang Yu & Tong Wang. (2022) Disposition study of the novel dipeptidyl peptidase 4 inhibitor cetagliptin in rats. Xenobiotica 52:5, pages 468-475.
Read now

Articles from other publishers (3)

Chen Zhou, Sufeng Zhou, Jie Wang, Lijun Xie, Zhanhui Lv, Yuqing Zhao, Lu Wang, Huan Luo, Daosheng Xie & Feng Shao. (2024) Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus. Frontiers in Endocrinology 15.
Crossref
Linong Ji, Jinmiao Lu, Leili Gao, Xiaoguang Yan, Jifang Li, Zhifeng Cheng, Lili Zhang, Junhang Tian, Ping Li, Jie Bai, Daosheng Xie, Jiahong Zhao, Juping Ding, Qiang Yu & Tong Wang. (2023) A randomized, double‐blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy. Diabetes, Obesity and Metabolism 25:12, pages 3788-3797.
Crossref
Linong Ji, Jinmiao Lu, Leili Gao, Changjiang Ying, Jiao Sun, Jie Han, Wenhua Zhao, Yunming Gao, Kun Wang, Xin Zheng, Daosheng Xie, Juping Ding, Jiahong Zhao, Qiang Yu & Tong Wang. (2023) Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled phase 3 trial. Diabetes, Obesity and Metabolism 25:12, pages 3671-3681.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.